PTC's business is organized into two product groups. The computer-aided design (CAD) group offers software for data authoring, including CAD software and augmented reality (AR). The second group, ...
PTC Therapeutics offers a compelling risk-reward profile, with its valuation not fully reflecting the upside from Sephience and potential ST-920 approval. Sephience, PTCT’s lead asset, has driven ...
WARREN, N.J., Sept. 21, 2026 /PRNewswire/ -- PTC Therapeutics, Inc., (NASDAQ: PTCT) today announced that it completed the previously announced agreement with Sangamo Therapeutics, Inc. to acquire ...
Ratings for PTC (NASDAQ:PTC) were provided by 7 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. In the table below, you'll find a summary of their recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results